Due to technical issues, the Customer Support line is currently unavailable. Please use the live chat or email communication.

Share Name Share Symbol Market Type Share ISIN Share Description
YourGene Health LSE:YGEN London Ordinary Share GB00BN31ZD89
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 12.00p 11.75p 12.25p 12.00p 11.625p 11.625p 368,613 10:26:41
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 6.1 -9.5 3.0 4.0 50.12

Yourgene Health PLC Appointment of Sole Corporate Broker

17/04/2019 4:50pm

UK Regulatory (RNS & others)

YourGene Health (LSE:YGEN)
Historical Stock Chart

1 Month : From Mar 2019 to Apr 2019

Click Here for more YourGene Health Charts.


RNS Number : 5400W

Yourgene Health PLC

17 April 2019

Yourgene Health plc

("Yourgene" or the "Company")

Appointment of Sole Corporate Broker

Manchester, UK - 17 April 2019: Yourgene Health (AIM: YGEN), the international molecular diagnostics group which commercialises genetic products and services, announces the appointment of Stifel Nicolaus Europe Limited as the Company's Sole Corporate Broker with immediate effect.

For more information, please contact: 
Yourgene Health plc                                 Tel: +44 (0)161 
 Lyn Rees, Chief Executive Officer                   667 1053 
 Barry Hextall, Chief Financial Officer 
 Joanne Cross, Head of Marketing 
Cairn Financial Advisers LLP (NOMAD)                Tel: +44 (0)20 7213 
 Liam Murray / James Caithie / Ludovico Lazzaretti   0880 
Stifel Nicolaus Europe Limited (Sole Corporate      Tel: +44 (0)20 7710 
 Broker)                                             7600 
 Nicholas Moore / Matthew Blawat / Ben Maddison 
Vigo Communications                                 Tel: +44 (0)20 7390 
 Ben Simons / Fiona Henson / Antonia Pollock         0238 

About Yourgene Health

Yourgene Health is an international molecular diagnostics group which develops and commercialises genetic products and services. The group works in partnership with global leaders in DNA technology to advance diagnostic science.

Our product development, research service and commercial capabilities extend across the lifecycle of genetic test development including regulatory submissions.

Yourgene Health's first commercialised products are non-invasive prenatal tests (NIPT) for Down's syndrome and other genetic disorders, targeting a share of an emerging billion-dollar global market.

Prenatal screening is an established clinical practice, but accuracy challenges with traditional methods are driving the need for NIPT and other DNA-based reproductive health testing solutions. Yourgene Health's customer-focused products and services support all types of customer, irrespective of size, geography and market maturity. Our commercial footprint is already established in the UK, Europe, the Middle East, Africa and Asia.

Through our technical expertise and partnerships, Yourgene Health is aiming to extend its genetic testing offering into complementary areas of reproductive health and oncology.

Yourgene Health is headquartered in Manchester, UK with offices in Taipei and Singapore. For more information visit www.yourgene-health.com and follow us on twitter @Yourgene_Health.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.



(END) Dow Jones Newswires

April 17, 2019 11:50 ET (15:50 GMT)

1 Year YourGene Health Chart

1 Year YourGene Health Chart

1 Month YourGene Health Chart

1 Month YourGene Health Chart
Your Recent History
YourGene H..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20190424 12:16:40